Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Joy
Joy is an MD/PhD candidate at the Icahn School of Medicine at Mount Sinai. She earned a BS (Biochemistry, Molecular Biology) and BA (Anthropology) from Brown, and completed a postbacc fellowship at the National Cancer Institute.
Michael
Michael is currently pursuing his dermatology residency training at the Harvard Combined Dermatology Residency Training Program in Boston, MA.